116 related articles for article (PubMed ID: 16902925)
1. Influence of the scyphostatin side chain on the mode of inhibition of neutral sphingomyelinase.
Wascholowski V; Giannis A; Pitsinos EN
ChemMedChem; 2006 Jul; 1(7):718-21. PubMed ID: 16902925
[No Abstract] [Full Text] [Related]
2. Synthesis and evaluation of three novel scyphostatin analogues as neutral sphingomyelinase inhibitors.
Pitsinos EN; Wascholowski V; Karaliota S; Rigou C; Couladouros EA; Giannis A
Chembiochem; 2003 Nov; 4(11):1223-5. PubMed ID: 14613115
[No Abstract] [Full Text] [Related]
3. Concise asymmetric total synthesis of scyphostatin, a potent inhibitor of neutral sphingomyelinase.
Fujioka H; Sawama Y; Kotoku N; Ohnaka T; Okitsu T; Murata N; Kubo O; Li R; Kita Y
Chemistry; 2007; 13(36):10225-38. PubMed ID: 17907134
[TBL] [Abstract][Full Text] [Related]
4. Short and efficient route to the fully functionalized polar core of scyphostatin.
Pitsinos EN; Cruz A
Org Lett; 2005 May; 7(11):2245-8. PubMed ID: 15901180
[TBL] [Abstract][Full Text] [Related]
5. Concise approach to the carbocyclic core of the naturally occurring sphingomyelinase inhibitor scyphostatin.
Mehta G; Modugu NR
J Org Chem; 2013 Apr; 78(7):3367-73. PubMed ID: 23442124
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antiapoptotic activity of a novel analogue of the neutral sphingomyelinase inhibitor scyphostatin.
Claus RA; Wüstholz A; Müller S; Bockmeyer CL; Riedel NH; Kinscherf R; Deigner HP
Chembiochem; 2005 Apr; 6(4):726-37. PubMed ID: 15751001
[TBL] [Abstract][Full Text] [Related]
7. Scyphostatin, a neutral sphingomyelinase inhibitor from a discomycete, Trichopeziza mollissima: taxonomy of the producing organism, fermentation, isolation, and physico-chemical properties.
Nara F; Tanaka M; Hosoya T; Suzuki-Konagai K; Ogita T
J Antibiot (Tokyo); 1999 Jun; 52(6):525-30. PubMed ID: 10470675
[TBL] [Abstract][Full Text] [Related]
8. Total synthesis of (+)-scyphostatin, a potent and specific inhibitor of neutral sphingomyelinase.
Inoue M; Yokota W; Murugesh MG; Izuhara T; Katoh T
Angew Chem Int Ed Engl; 2004 Aug; 43(32):4207-9. PubMed ID: 15307088
[No Abstract] [Full Text] [Related]
9. Synthesis and biochemical investigation of scyphostatin analogues as inhibitors of neutral sphingomyelinase.
Arenz C; Gartner M; Wascholowski V; Giannis A
Bioorg Med Chem; 2001 Nov; 9(11):2901-4. PubMed ID: 11597471
[TBL] [Abstract][Full Text] [Related]
10. Studies toward the total synthesis of scyphostatin: first entry to the highly functionalized cyclohexenone segment.
Izuhara T; Katoh T
Org Lett; 2001 May; 3(11):1653-6. PubMed ID: 11405678
[TBL] [Abstract][Full Text] [Related]
11. Entamoeba histolytica: molecular cloning and characterization of a novel neutral sphingomyelinase.
Mendoza-Macías CL; Barrios-Ceballos MP; Anaya-Velázquez F; Nakada-Tsukui K; Nozaki T; Padilla-Vaca F
Exp Parasitol; 2010 Jul; 125(3):279-85. PubMed ID: 20138872
[TBL] [Abstract][Full Text] [Related]
12. Sphingomyelin analogues as inhibitors of sphingomyelinase.
Taguchi M; Sugimoto K; Goda K; Akama T; Yamamoto K; Suzuki T; Tomishima Y; Nishiguchi M; Arai K; Takahashi K; Kobori T
Bioorg Med Chem Lett; 2003 Jun; 13(12):1963-6. PubMed ID: 12781174
[TBL] [Abstract][Full Text] [Related]
13. Biological activities of scyphostatin, a neutral sphingomyelinase inhibitor from a discomycete, Trichopeziza mollissima.
Nara F; Tanaka M; Masuda-Inoue S; Yamasato Y; Doi-Yoshioka H; Suzuki-Konagai K; Kumakura S; Ogita T
J Antibiot (Tokyo); 1999 Jun; 52(6):531-5. PubMed ID: 10470676
[TBL] [Abstract][Full Text] [Related]
14. Stereoselective reactions of a (-)-quinic acid-derived enone: application to the synthesis of the core of scyphostatin.
Murray LM; O'Brien P; Taylor RJ
Org Lett; 2003 May; 5(11):1943-6. PubMed ID: 12762692
[TBL] [Abstract][Full Text] [Related]
15. Dynamic kinetic resolution during a vinylogous Payne rearrangement: a concise synthesis of the polar pharmacophoric subunit of (+)-scyphostatin.
Hoye TR; Jeffrey CS; Nelson DP
Org Lett; 2010 Jan; 12(1):52-5. PubMed ID: 19968321
[TBL] [Abstract][Full Text] [Related]
16. Small molecule inhibitors of acid sphingomyelinase.
Arenz C
Cell Physiol Biochem; 2010; 26(1):1-8. PubMed ID: 20501999
[TBL] [Abstract][Full Text] [Related]
17. Stereoselective total synthesis of (+)-Scyphostatin via a pi-facially selective Diels-Alder reaction.
Takagi R; Miyanaga W; Tojo K; Tsuyumine S; Ohkata K
J Org Chem; 2007 May; 72(11):4117-25. PubMed ID: 17477576
[TBL] [Abstract][Full Text] [Related]
18. Purification and characterization of a magnesium-dependent neutral sphingomyelinase from bovine brain.
Bernardo K; Krut O; Wiegmann K; Kreder D; Micheli M; Schäfer R; Sickman A; Schmidt WE; Schröder JM; Meyer HE; Sandhoff K; Krönke M
J Biol Chem; 2000 Mar; 275(11):7641-7. PubMed ID: 10713073
[TBL] [Abstract][Full Text] [Related]
19. A short and efficient route to novel scyphostatin analogues.
Runcie KA; Taylor RJ
Org Lett; 2001 Oct; 3(21):3237-9. PubMed ID: 11594803
[TBL] [Abstract][Full Text] [Related]
20. Plasmodium falciparum phospholipase C hydrolyzing sphingomyelin and lysocholinephospholipids is a possible target for malaria chemotherapy.
Hanada K; Palacpac NM; Magistrado PA; Kurokawa K; Rai G; Sakata D; Hara T; Horii T; Nishijima M; Mitamura T
J Exp Med; 2002 Jan; 195(1):23-34. PubMed ID: 11781362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
